Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-098966
Filing Date
2010-11-02
Accepted
2010-11-01 19:39:31
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c05798e10vq.htm 10-Q 698903
2 EXHIBIT 31.1 c05798exv31w1.htm EX-31.1 5943
3 EXHIBIT 31.2 c05798exv31w2.htm EX-31.2 6252
4 EXHIBIT 32.1 c05798exv32w1.htm EX-32.1 2645
5 EXHIBIT 32.2 c05798exv32w2.htm EX-32.2 2754
  Complete submission text file 0000950123-10-098966.txt   8469277

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20100930.xml EX-101.INS 948017
7 EX-101 SCHEMA DOCUMENT celg-20100930.xsd EX-101.SCH 70299
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20100930_cal.xml EX-101.CAL 77310
9 EX-101 LABELS LINKBASE DOCUMENT celg-20100930_lab.xml EX-101.LAB 547185
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20100930_pre.xml EX-101.PRE 318462
11 EX-101 DEFINITION LINKBASE DOCUMENT celg-20100930_def.xml EX-101.DEF 106761
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 101156121
SIC: 2834 Pharmaceutical Preparations